MBX Biosciences (MBX) Cash & Current Investments (2023 - 2026)
MBX Biosciences' Cash & Current Investments came in at $418.58 million for Q2 2026, up 86.1% from $224.91 million a year earlier but down 4.9% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, MBX Biosciences' Cash & Current Investments was $373.71 million, up 42.6% from FY2024.
- Going back by year, Cash & Current Investments was $262.15 million in FY2024 (+224.9%) and $80.68 million in FY2023.
- The five-year range for quarterly Cash & Current Investments is $80.68 million (Q4 2023) to $439.98 million (Q1 2026).
- Year-over-year, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 95.5% over the last five quarters.
- Business Quant data shows MBX's Cash & Current Investments at $439.98 million (Q1 2026), $373.71 million (Q4 2025) and $391.67 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | MBX Biosciences | 2.31 Bn | 689.81 Mn | - | 418.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 418.58 Mn |
| Mar 31, 2026 | 439.98 Mn |
| Dec 31, 2025 | 373.71 Mn |
| Sep 30, 2025 | 391.67 Mn |
| Jun 30, 2025 | 224.91 Mn |
| Mar 31, 2025 | 240.79 Mn |
| Dec 31, 2024 | 262.15 Mn |
| Sep 30, 2024 | 277.06 Mn |
| Dec 31, 2023 | 80.68 Mn |
API Access
MBX Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();